SBLATTERO, DANIELE
 Distribuzione geografica
Continente #
EU - Europa 1.967
NA - Nord America 1.695
AS - Asia 352
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 1
Totale 4.021
Nazione #
US - Stati Uniti d'America 1.684
IE - Irlanda 715
SE - Svezia 342
DE - Germania 305
UA - Ucraina 260
CN - Cina 182
FI - Finlandia 168
IT - Italia 130
HK - Hong Kong 76
IN - India 39
GB - Regno Unito 24
SG - Singapore 19
IR - Iran 16
BE - Belgio 13
CA - Canada 9
TR - Turchia 9
VN - Vietnam 8
EU - Europa 6
FR - Francia 3
RU - Federazione Russa 3
IL - Israele 2
MX - Messico 2
RO - Romania 2
BD - Bangladesh 1
CL - Cile 1
GR - Grecia 1
NO - Norvegia 1
Totale 4.021
Città #
Dublin 708
Jacksonville 483
Dearborn 219
Wilmington 125
Chandler 106
Lawrence 88
Princeton 88
Beijing 84
Ann Arbor 80
Hong Kong 76
San Mateo 75
Andover 58
Piemonte 53
Düsseldorf 31
Ashburn 20
Boardman 17
Kunming 17
Hefei 15
Monmouth Junction 14
Brussels 13
Nanjing 13
Singapore 11
Woodbridge 11
Kocaeli 9
Norwalk 9
Bremen 8
Dong Ket 8
Toronto 8
Fairfield 7
Helsinki 7
Philadelphia 7
Ardabil 6
Fuzhou 6
Grafing 6
Guangzhou 6
Houston 6
Jinan 6
Leawood 6
Nanchang 6
Seattle 6
Shenyang 6
Zanjan 6
Milan 5
Trieste 5
Turin 5
Dallas 4
Novara 4
Vercelli 4
Augusta 3
Redmond 3
Sacramento 3
Chaoyang 2
Chengdu 2
Chongqing 2
Des Moines 2
Henderson 2
Horia 2
Kashan 2
Menlo Park 2
Scuola 2
Seregno 2
Torino 2
Wuhan 2
Bangalore 1
Bolzaneto 1
Cambridge 1
Cividale Del Friuli 1
Easley 1
Eboli 1
Fremont 1
Huzhou 1
Kemerovo 1
Malgrate 1
Mexico 1
Mexico City 1
Minneapolis 1
Mumbai 1
Mülheim 1
Nanning 1
Nuremberg 1
Oggiono 1
Oslo 1
Portland 1
Quarto D'asti 1
Rome 1
Shanghai 1
Shaoxing 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Teramo 1
Tianjin 1
Udine 1
Winnipeg 1
Xian 1
Zhengzhou 1
Totale 2.627
Nome #
RECOMBINANT ANTIBODIES AGAINST HUMAN TYPE II TRANSGLUTAMINASE AND USES THEREOF 98
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo 94
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 80
A reliable screening procedure for coeliac disease in clinical practice 79
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 78
A definitive set of oligonucleotide primers for amplifying human V regions 74
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 74
Engineering mammalian cell factories with SINEUP noncoding RNAs to improve translation of secreted proteins 74
Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors 68
An Air-well sparging minifermenter system for high-throughput protein production. 65
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ 64
High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids 61
InteractomeSeq: a web server for the identification and profiling of domains and epitopes from phage display and next generation sequencing data 61
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 59
The RNA-binding protein ILF3 binds to transposable element sequences in SINEUP lncRNAs 59
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 58
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives 56
Recombinant antibodies against CD55 and CD59 and uses thereof 56
Recombinant antibodies against CD55 and CD59 and uses thereof 56
Antibody library selection by the beta-lactamase protein fragment complementation assay 56
Treatment of arthritis models by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 53
Identification of novel proteins binding the AU-rich element of α-prothymosin mRNA through the selection of open reading frames (RIDome) 52
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 50
Antibodies in proteomics I: generating antibodies 50
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 50
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 49
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 49
Primer sets for cloning the human repertoire of T cell Receptor Variable regions 48
A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome. 48
Dpp10 - A New Putative Regulatory ß-subunit Of Ito In Failing And Non-failing Human Heart 48
Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis 48
Anti-transglutaminase antibodies and age 47
Phage display technology for human monoclonal antibodies 47
Deglycosylation effects of tunicamycin and neuraminidase on Kv4.3 channel complex 47
Anti transglutaminase antibodies cause ataxia in mice 46
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of I (to) channel complex 46
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 46
Exploiting recombination in single bacteria to make large phage antibody libraries 45
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 45
Binders based on dimerised immunoglobulin VH domains 43
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 43
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 43
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 43
Autoantibodies as predictors of disease 42
Method for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof 42
Predicting antigenic peptides suitable for the selection of phage antibodies 42
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 41
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease 41
Profiling celiac disease antibody repertoire. 41
Anti-idiotypic response in mice expressing human autoantibodies 40
An albumin-derived peptide scaffold capable of binding and catalysis. 40
Testing for anti-human transglutaminase antibodies in saliva is not useful for diagnosis of celiac disease 39
Characterizing monoclonal antibody epitopes by filtered gene fragment phage display 39
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 38
Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies 38
Profiling the autoantibody repertoire by screening phage-displayed human cDNA libraries 38
The transmembrane beta-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current Ito 38
Filtering "genic" open reading frames from genomic DNA samples for advanced annotation 38
Rapid interactome profiling by massive sequencing 38
A deep-blue OLED-based biochip for protein microarray fluorescence detection. 38
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 37
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 37
Characterization of the Anti-Tissue Transglutaminase Antibody Response in Nonobese Diabetic Mice 37
Mass screening for coeliac disease using antihuman transglutaminase antibody assay 37
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 37
Simple scale-up of recombinant antibody production using an UCOE containing vector 37
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease 35
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor 35
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells. 35
Plasmid incompatibility: more compatible than previously thought? 34
The gut as site of production of autoimmune antibodies 34
Development of a novel rapid non-invasive screening test for coeliac disease 33
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5. 33
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 33
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics. 33
Selecting open reading frames from DNA 32
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. 32
Dual sugar gut-permeability testing on blood drop in animal models 32
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine 31
Selection and characterization of a novel agonistic human recombinant anti-TRAIL_R2 minibody with anti_leukemic activity 31
Using archaeal histones for precise DNA fragmentation 31
Cryptic gluten intolerance in type 1 diabetes: identifying suitable candidates for a gluten free diet 30
Mucosal tissue transglutaminase expression in celiac disease 30
Role of the C-terminal fragment of osteopontin in multiple sclerosis 30
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 29
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 29
Gluten ataxia: passive transfer in a mouse model 27
Defining the Helicobacter pylori Disease-Specific Antigenic Repertoire 21
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 17
Totale 4.058
Categoria #
all - tutte 21.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/2020900 7 4 78 11 151 134 199 41 100 70 103 2
2020/2021597 90 0 85 14 59 16 91 14 93 19 97 19
2021/2022625 38 16 108 79 33 2 65 17 44 40 66 117
2022/20231.227 94 44 68 28 43 111 22 66 699 3 31 18
2023/2024251 29 14 22 8 61 5 72 5 0 1 24 10
Totale 4.058